Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Everything REMS Under The Sun: FDA Lays Out Ambitious PDUFA V Meeting Agenda

This article was originally published in The Pink Sheet Daily

Executive Summary

The struggles that industry and FDA face when trying to best standardize and evaluate REMS are illustrated by the dozens of topics jammed into the two-day meeting.


Related Content

How To Speak REMS: Structured Product Labeling Seen As Route To Standardization
Shared REMS Systems Show Challenges Of Standardization – Could PDUFA V Help?
REMS Standardization Gets Boost From Lotronex Sticker Review
Lotronex REMS’ Verification Process Should Be Electronic, FDA Panel Says
Prometheus’ Lotronex REMS Could Lose Its Sticker Verification Requirement
FDAAA Impact Analysis (Year 5): The REMS Paradox
Declaring Victory: How FDA Releases REMS
FDA Plans To Improve REMS Effectiveness With Guidance On Goals And Metrics
PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones
REMS Reform Looks To Be Theme Of PDUFA V: Stakeholders Call For Standardization, Earlier Notice





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts